Wahed Invest LLC Has $4.19 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wahed Invest LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,519 shares of the medical equipment provider’s stock after buying an additional 981 shares during the period. Intuitive Surgical accounts for approximately 0.7% of Wahed Invest LLC’s investment portfolio, making the stock its 27th biggest position. Wahed Invest LLC’s holdings in Intuitive Surgical were worth $4,185,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in ISRG. Massachusetts Financial Services Co. MA bought a new stake in Intuitive Surgical during the third quarter worth about $558,807,000. International Assets Investment Management LLC lifted its position in Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares during the period. FMR LLC lifted its position in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Strategic Financial Concepts LLC lifted its holdings in shares of Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock worth $1,184,000 after acquiring an additional 265,461 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after acquiring an additional 210,363 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 51,023 shares of company stock worth $26,384,247 over the last quarter. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on ISRG shares. Truist Financial raised their price objective on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday, October 14th. Mizuho raised their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Finally, Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $541.33.

Intuitive Surgical Stock Down 0.4 %

ISRG opened at $547.65 on Friday. The company has a market capitalization of $195.06 billion, a price-to-earnings ratio of 88.05, a PEG ratio of 5.33 and a beta of 1.38. The firm has a 50-day moving average price of $514.78 and a 200-day moving average price of $472.60. Intuitive Surgical, Inc. has a twelve month low of $307.72 and a twelve month high of $552.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.